Text Size
71165 studies found for:    pharmacology

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: electrical cardioversion;   Drug: propafenone
2 Completed Pilot Study of Pharmacology of Paracetamol Administered Per-oral Mucosa
Condition: Healthy
Interventions: Drug: Kinetics of plasma concentrations of paracetamol;   Drug: Placebo
3 Completed Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
Condition: Healthy
Interventions: Drug: MDA;   Drug: Placebo
4 Completed Pharmacology Study of Aerosolized Liposomal
Conditions: Lung Diseases;   Cancer
Intervention: Drug: L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
5 Not yet recruiting Pharmacology of Exenatide in Pediatric Sepsis
Conditions: Septic Shock;   Inflammation;   Glucose Homeostasis;   Organ Dysfunction;   Health-related Quality of Life
Interventions: Drug: Exenatide;   Drug: Exenatide vehicle
6 Completed Study of Pharmacology of 17-OHPC in Pregnancy
Condition: Pregnancy
Interventions: Drug: 17-OHPC;   Procedure: Blood Draws
7 Recruiting Pharmacological Management of Delirium
Conditions: Delirium;   Cognitive Impairment
Interventions: Behavioral: Reduced exposure to anticholinergics;   Procedure: Reduced exposure to benzodiazepines;   Drug: Haloperidol;   Procedure: Usual care
8 Recruiting Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumors;   Lymphomas
Intervention: Drug: Camptothecin-20-O-Propionate Hydrate (CZ48)
9 Completed Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
Condition: Asthma
Interventions: Drug: Test treatments CHF 1535 100/6 pMDI (Foster®) TEST1;   Drug: CHF 1535 100/6 pMDI (Foster®) using AeroChamber Plus™ (TEST 2).;   Drug: BDP pMDI 100 µg (Qvar®) plus formoterol fumarate pMDI 6 µg (Atimos®) (REF);   Drug: CHF 1535 100/6 pMDI (Foster®) (CTR)
10 Completed A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin
Conditions: Hypercholesterolemia;   Hyperlipoproteinemia
Interventions: Drug: Pravastatin;   Drug: Lifibrol
11 Completed Alefacept Mechanism of Action in Psoriasis
Condition: Psoriasis
Intervention: Drug: Mechanism of action of alefacept
12 Recruiting A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
Condition: Rheumatoid Arthritis
Interventions: Drug: Remicade;   Drug: Orencia;   Drug: Ro-Actemra;   Drug: Mabthera
13 Completed A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes
Intervention: Drug: saxaglipitin
14 Recruiting Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium
Condition: Delirium
Interventions: Drug: Quetiapine;   Drug: Haloperidol;   Drug: Placebo
15 Completed Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
Condition: Rheumatoid Arthritis
Intervention: Drug: MRA(Tocilizumab)
16 Completed Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-Responsive Clinical Pharmacology Study
Condition: Cerebral Infarction
Intervention: Drug: MCI-9042
17 Unknown † Clinical Biological and Pharmacological Factors Influencing Stroke Outcome
Condition: Stroke
Intervention:
18 Active, not recruiting Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma
Condition: Smoldering Multiple Myeloma
Interventions: Drug: IPH2101 0.2 mg/kg;   Drug: IPH2101 2 mg/kg
19 Completed Measuring Placebo Effect by Elimination and Investigating Mechanism of Action
Conditions: Placebo Effect;   Placebo Mechanisms of Action
Intervention: Drug: caffeine/placebo
20 Completed Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity
Condition: Insulin Resistance
Interventions: Drug: Atropine;   Drug: Physostigmine;   Drug: Placebo Sodium
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years